NOT KNOWN FACTUAL STATEMENTS ABOUT ABBV-744 PRECLINICAL STUDIES AND RESULTS

In Section A, participants will acquire distinctive doses and schedules of oral ABBV-744 tablet to discover Protected dosing regimen. More contributors are going to be enrolled at the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 might be presented as "include-on" therapy. In Section C, partic